Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 1097

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 1097
---
 person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |

| I. | The undersigned registrant hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus pursuant to Items 4, 10(b), 11, or 13 of this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. |

| J. | The undersigned registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in the registration statement when it became effective. |

II-7

#### SIGNATURESPursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement on FormS-4to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tampa, FL on May 6, 2025.TUHURA BIOSCIENCES, INC.By:/s/ James A. Bianco, M.D.Name: James A. Bianco, M.D.Title:  Chief Executive OfficerPursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities indicated:SIGNATURETITLEDATE/s/ James A. Bianco, M.D.James A. Bianco, M.D.Chief Executive OfficerChief Executive Officer and Director“(Principal Executive Officer)”May 6, 2025/s/ *Dan DearbornChief Financial OfficerChief Financial Officer“(Principal Financial and Accounting Officer)”May 6, 2025/s/ *James Manuso, Ph.D.DirectorMay 6, 2025/s/ *Alan List, M.D.DirectorMay 6, 2025/s/ *George NgDirectorMay 6, 2025/s/ *Robert HoffmanDirectorMay 6, 2025Craig TendlerDirectorMay 6, 2025*By: /s/